SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Fundamental Value Investing
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bruwin who wrote (4397)5/20/2020 6:23:53 PM
From: Sergio H  Read Replies (1) of 4719
 
Thank you Bruwin. I had a hunch ZYXI would score well. I've been invested in this stock before it uplisted to Nasdaq and this is the stock that "opened my eyes" to explore OTC stocks. ZYXI has zero competitors for the last couple of years and has been adding sales staff to take advantage of the opportunity. There's really no barrier to entry, something Buffett would not like and I think the landscape is changing for them as they have been dropped by one of their largest insurance companies. This hasn't been reported yet, so investors are in the dark. They are dependent on insurance reimbursement for their medical device sales and if one insurance carrier dropped them.... Goes to show that you have to look if the numbers will hold up. Has there been a change that will effect future results.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News